158
Views
63
CrossRef citations to date
0
Altmetric
Original Article

Clinical Course and Pathologic Findings After Gliadel® and Radiotherapy for Newly Diagnosed Malignant Glioma: Implications for Patient Management

, M.D., , M.D., , M.D., , Sc.M., , M.D., , M.D., , M.D., , M.D. & show all
Pages 1-9 | Published online: 17 Feb 2004

References

  • Brem H., Mahaley M. S., Jr., Vick N. A., Black K. L., Schold S. C., Jr., Burger P. C., Friedman A. H., Ciric I. S., Eller T. W., Cozzens J. W., Kenealy J. N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 1991; 74(3)441–446, [PUBMED], [INFOTRIEVE]
  • Grossman S. A., Reinhard C., Colvin O. M., Chasin M., Brundrett R., Tamargo R. J., Brem H. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J. Neurosurg. 1992; 76(4)640–647, [PUBMED], [INFOTRIEVE]
  • Brem H., Piantadosi S., Burger P. C., Walker M., Selker R., Vick N. A., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S. C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Polymer-Brain Tumor Group 1995; 345: 1008–1012
  • Brem H., Ewend M. G., Piantadosi S., Greenhoot J., Burger P. C., Sisti M. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J. Neuro-Oncol. 1995; 26: 111–123
  • Valtonen S., Timonen U., Toivanen P., Kalimo H., Kivipelto L., Heiskanen O., Unsgaard G., Kuurne T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997; 41(1)44–49, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Westphal M., Devault P., Hilt D., Dana C., Bortey E., Olivares R., Warnke P. C., Whittle I. R., Jääskeläinen J., Ram Z. Placebo controlled multicenter double blind randomized prospective phase III trial of local chemotherapy with biodegradable carmustine implants in 240 patients with malignant gliomas: final results. Fifth Annual Meeting of the Society for Neuro-Oncology in Neuro-Oncology. 2000; Vol. 4: 301
  • Subach B. R., Witham T. F., Kondziolka D., Lunsford L., Bozik M., Schiff D. Morbidity and survival after 1,3-bis(2-chloroethyl)-1 Nitrosourea Wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 1999; 45(1)17, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brem H., Tamargo R. J., Olivi A., Pinn M., Weingart J. D., Wharam M., Epstein J. I. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J. Neurosurg. 1994; 80: 283–290, [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.